Roth Capital Downgrades Celsion Corp (CLSN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Celsion (CLSN) Slammed 83% Upon Trade Resumption
January 31, 2013 7:34 AM ESTCelsion Corporation (NASDAQ: CLSN) has resumed trading and is down 83% after ThermoDox Missed Primary Endpoint in Phase III HEAT... More
Celsion (CLSN) will resume trading at 7:30AM after Trial Failure
January 31, 2013 7:27 AM ESTCelsion Corporation (NASDAQ: CLSN) will resume trading at 7:30AM ThermoDox Missed Primary Endpoint in Phase III HEAT... More
Celsion (CLSN) Says ThermoDox Missed Primary Endpoint in Phase III HEAT
January 31, 2013 7:03 AM ESTCelsion Corporation (NASDAQ: CLSN) announced that ThermoDox® in combination with radiofrequency ablation (RFA) did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.
Specifically, Celsion has determined, after conferring... More
Celsion (CLSN) to Hold Phase III HEAT Call on Jan. 31; Receives Priority Trial Designation
January 30, 2013 4:15 PM ESTCelsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it will host a conference call and webcast at 8:00 a.m. Eastern Time on Thursday, January 31, 2013 to present the top-line results from its pivotal Phase III HEAT Study with ThermoDox® in combination... More
Celsion (CLSN) trading halted with news pending
January 30, 2013 4:03 PM ESTCelsion Corporation (NASDAQ: CLSN) trading halted with news pending.... More
